Clinical Trial Update: The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE

View source ↗

Summary

The completed trial investigated how common thiopurine methyltransferase (TPMT) genetic polymorphisms are among patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Bangladesh Medical University | Conditions: Genetic Polymorphism | Status: COMPLETED